Brief Articles
Copyright ©2009 The WJG Press and Baishideng.
World J Gastroenterol. Aug 28, 2009; 15(32): 4028-4036
Published online Aug 28, 2009. doi: 10.3748/wjg.15.4028
Table 4 Prevalence of HBx and core promoter mutations in samples with different clinical diagnosis
Characteristicsn(%) in each clinical diagnosis
CH (n = 61)LC (n = 62)HCC
Total (n = 171)P
With LC (n = 12)Without LC (n = 36)All HCC (n = 48)CH vs LCCH vs All HCCLC vs All HCCCH vs LC vs All HCC
Genotype B/C (%B)46/15 (75.4)44/18 (71.0)10/2 (83.3)26/10 (72.2)36/12 (75.0)126/45 (73.7)NSNSNSNS
BCP mutations
C1726A/T1727(C/T)24 (39.3)8 (12.9)4 (33.3)7 (19.4)11 (22.9)43 (34.1)0.002NS0.0150.003
T1753V11 (18.0)29 (46.8)2 (16.7)9 (25.0)11 (22.9)51 (40.5)0.015NS0.0180.004
A1762T12 (19.7)38 (61.3)6 (50.0)21 (58.3)27 (56.3)77 (61.1)< 0.001< 0.001NS< 0.001
G1764A13 (21.3)38 (61.3)5 (41.7)21 (58.3)26 (54.2)77 (61.1)< 0.0010.0002NS< 0.001
C1766T1 (1.6)3 (4.8)1 (8.3)1 (2.8)2 (4.2)6 (4.8)NSNSNSNS
T1768A1 (1.6)2 (3.2)1 (8.3)2 (5.6)3 (6.3)6 (4.8)NSNSNSNS
A1762T/G1764A12 (19.7)37 (59.7)5 (41.7)21 (58.3)26 (54.2)75 (59.5)< 0.0010.0004NS< 0.001